Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD.

We failed to identify significant differences in the APRs expression according to the use of treatment. Associations between acute phase reactants gene expression and their plasma concentrations Plasma CRP showed a trend toward higher levels in COPD patients (4.4±1.73 mg/mL) than in control group (3.8±2.04 mg/mL, P >0.05).

also in 47,213 other papers